Switch to:
Also traded in: Germany
» Details

Insider Trades

Latest Guru Trades with AMS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621999    SIC: 8071
Compare:OTCPK:BNKL, AMEX:SSY, OTCPK:CCEL, OTCPK:BICX, OTCPK:PFHO, OTCPK:SPIN, OTCPK:CPAI, AMEX:HH, OTCPK:FCHS, OTCPK:WNDM, OTCPK:FDNH, OTCPK:USNU, OTCPK:GRST, OTCPK:CAMDF, NAS:JYNT, OTCPK:MIHI, OTCPK:AMEH, OTCPK:CATS, NYSE:ADPT, AMEX:HLTH » details
Traded in other countries:AZS.Germany,
American Shared Hospital Services provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to seventeen (17) medical centers in sixteen (16) states in the United States and two medical centers in Turkey.

American Shared Hospital Services was incorporated in the State of California in 1983 and its predecessor, Ernest A. Bates, M.D., Ltd. (d/b/a American Shared Hospital Services), a California limited partnership, was formed in June 1980. It provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to seventeen (17) medical centers in sixteen (16) states in the United States and two medical centers in Turkey, as of March 1, 2013. The Gamma Knife stereotactic radiosurgery is a non-invasive procedure and an alternative to conventional brain surgery or can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. Compared to conventional surgery, Gamma Knife radiosurgery usually involves shorter patient hospitalization, lower risk of complications and can be provided at a lower cost. Typically, Gamma Knife patients resume their pre-surgical activities one or two days after treatment. The Gamma Knife treats patients with 201 single doses of gamma rays that are focused with great precision on small and medium sized, well circumscribed and critically located structures in the brain. During 2006 Elekta introduced a new Gamma Knife model, the Perfexion unit, which treats patients with 192 single doses of gamma rays and will also provide the ability to perform procedures on areas of the upper cervical spine. The Gamma Knife delivers a concentrated dose of gamma rays from Cobalt-60 sources housed in the Gamma Knife. The Cobalt-60 sources converge at the target area and deliver a dose that is high enough to destroy the diseased tissue without damaging surrounding healthy tissue. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). Research is being conducted to determine whether the Gamma Knife can be effective in the treatment of epilepsy and other functional disorders. Conventional neurosurgery, radiation therapy and other radiosurgery devices are the primary competitors of Gamma Knife radiosurgery. The Medicare program is administered by the Centers for Medicare and Medicaid Services of the U.S. Department of Health and Human Services.

Ratios

vs
industry
vs
history
PE Ratio 29.51
AMS's PE Ratio is ranked lower than
57% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 25.24 vs. AMS: 29.51 )
Ranked among companies with meaningful PE Ratio only.
AMS' s PE Ratio Range Over the Past 10 Years
Min: 9.11  Med: 24.11 Max: 406.25
Current: 29.51
9.11
406.25
PE Ratio without NRI 29.51
AMS's PE Ratio without NRI is ranked lower than
58% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 26.44 vs. AMS: 29.51 )
Ranked among companies with meaningful PE Ratio without NRI only.
AMS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.11  Med: 24.11 Max: 400
Current: 29.51
9.11
400
Price-to-Owner-Earnings 8.33
AMS's Price-to-Owner-Earnings is ranked higher than
88% of the 93 Companies
in the Global Medical Care industry.

( Industry Median: 27.99 vs. AMS: 8.33 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
AMS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.09  Med: 6.56 Max: 114.58
Current: 8.33
2.09
114.58
PB Ratio 1.06
AMS's PB Ratio is ranked higher than
86% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 2.73 vs. AMS: 1.06 )
Ranked among companies with meaningful PB Ratio only.
AMS' s PB Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.66 Max: 1.95
Current: 1.06
0.26
1.95
PS Ratio 1.28
AMS's PS Ratio is ranked higher than
58% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 1.67 vs. AMS: 1.28 )
Ranked among companies with meaningful PS Ratio only.
AMS' s PS Ratio Range Over the Past 10 Years
Min: 0.24  Med: 0.76 Max: 1.92
Current: 1.28
0.24
1.92
Price-to-Free-Cash-Flow 3.45
AMS's Price-to-Free-Cash-Flow is ranked higher than
97% of the 115 Companies
in the Global Medical Care industry.

( Industry Median: 23.76 vs. AMS: 3.45 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
AMS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0.87  Med: 2.37 Max: 56
Current: 3.45
0.87
56
Price-to-Operating-Cash-Flow 2.85
AMS's Price-to-Operating-Cash-Flow is ranked higher than
95% of the 168 Companies
in the Global Medical Care industry.

( Industry Median: 14.75 vs. AMS: 2.85 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AMS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.59  Med: 1.76 Max: 4.5
Current: 2.85
0.59
4.5
EV-to-EBIT 13.20
AMS's EV-to-EBIT is ranked higher than
75% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 20.76 vs. AMS: 13.20 )
Ranked among companies with meaningful EV-to-EBIT only.
AMS' s EV-to-EBIT Range Over the Past 10 Years
Min: 7  Med: 13.6 Max: 75.6
Current: 13.2
7
75.6
EV-to-EBITDA 5.06
AMS's EV-to-EBITDA is ranked higher than
95% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 15.90 vs. AMS: 5.06 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.9  Med: 5 Max: 7.2
Current: 5.06
2.9
7.2
Shiller PE Ratio 1242.30
AMS's Shiller PE Ratio is ranked lower than
98% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 29.68 vs. AMS: 1242.30 )
Ranked among companies with meaningful Shiller PE Ratio only.
AMS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 2.44  Med: 12.44 Max: 1305.47
Current: 1242.3
2.44
1305.47
Current Ratio 0.78
AMS's Current Ratio is ranked lower than
79% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.29 vs. AMS: 0.78 )
Ranked among companies with meaningful Current Ratio only.
AMS' s Current Ratio Range Over the Past 10 Years
Min: 0.36  Med: 1.5 Max: 4.13
Current: 0.78
0.36
4.13
Quick Ratio 0.78
AMS's Quick Ratio is ranked lower than
74% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.15 vs. AMS: 0.78 )
Ranked among companies with meaningful Quick Ratio only.
AMS' s Quick Ratio Range Over the Past 10 Years
Min: 0.36  Med: 1.5 Max: 4.13
Current: 0.78
0.36
4.13
Days Sales Outstanding 88.31
AMS's Days Sales Outstanding is ranked lower than
89% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 42.10 vs. AMS: 88.31 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 67.01  Med: 79.09 Max: 93.87
Current: 88.31
67.01
93.87
Days Payable 10.87
AMS's Days Payable is ranked lower than
87% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 39.14 vs. AMS: 10.87 )
Ranked among companies with meaningful Days Payable only.
AMS' s Days Payable Range Over the Past 10 Years
Min: 7.13  Med: 13.46 Max: 27.58
Current: 10.87
7.13
27.58

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -5.20
AMS's 3-Year Average Share Buyback Ratio is ranked lower than
61% of the 121 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. AMS: -5.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AMS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -10.6  Med: -0.1 Max: 8
Current: -5.2
-10.6
8

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 1.07
AMS's Price-to-Tangible-Book is ranked higher than
90% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 4.09 vs. AMS: 1.07 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AMS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.27  Med: 0.74 Max: 1.83
Current: 1.07
0.27
1.83
Price-to-Intrinsic-Value-Projected-FCF 0.43
AMS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
98% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. AMS: 0.43 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AMS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.11  Med: 0.31 Max: 0.54
Current: 0.43
0.11
0.54
Price-to-Median-PS-Value 1.70
AMS's Price-to-Median-PS-Value is ranked lower than
85% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. AMS: 1.70 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AMS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.15  Med: 1.11 Max: 3.08
Current: 1.7
0.15
3.08
Price-to-Graham-Number 1.18
AMS's Price-to-Graham-Number is ranked higher than
81% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 2.39 vs. AMS: 1.18 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AMS' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.09  Med: 0.95 Max: 3.29
Current: 1.18
0.09
3.29
Earnings Yield (Greenblatt) % 7.61
AMS's Earnings Yield (Greenblatt) % is ranked higher than
80% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. AMS: 7.61 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AMS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.3  Med: 7.3 Max: 14.4
Current: 7.61
1.3
14.4
Forward Rate of Return (Yacktman) % 7.65
AMS's Forward Rate of Return (Yacktman) % is ranked lower than
57% of the 112 Companies
in the Global Medical Care industry.

( Industry Median: 9.73 vs. AMS: 7.65 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AMS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 7.1  Med: 22.9 Max: 57.1
Current: 7.65
7.1
57.1

More Statistics

Revenue (TTM) (Mil) $17.80
EPS (TTM) $ 0.14
Beta0.93
Short Percentage of Float0.14%
52-Week Range $1.71 - 4.55
Shares Outstanding (Mil)5.37
» More Articles for AMS

Headlines

Articles On GuruFocus.com
American Shared Hospital Services: Can a Gamma Knife Generate Alpha? Apr 30 2012 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 15 2010 
American Shared Hospital Services (AMS) CHAIRMAN AND CEO, 10% Owner Shared Hospital Services America Sep 14 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 16 2010 
American Shared Hospital Services Reports Operating Results (10-Q) May 17 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 16 2009 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 14 2009 
American Shared Hospital Services Reports Operating Results (10-Q) May 15 2009 

More From Other Websites
Anglo American Platinum returns to profit, still no dividend Feb 15 2017
South Africa's Amplats swings to 2016 profit, but still no dividend Feb 15 2017
South Africa's Amplats CEO injured by buffalo Feb 08 2017
Sibanye looking for another South African asset Feb 06 2017
Sibanye looking for another South African asset Feb 06 2017
ETFs with exposure to American Shared Hospital Services : January 11, 2017 Jan 11 2017
South Africa's Sibanye pays $2.2 bln for Stillwater in U.S. move Dec 09 2016
Anglo American Platinum Limited – Union mine Spud shaft incident Nov 21 2016
AMERICAN SHARED HOSPITAL SERVICES Financials Nov 18 2016
American Shared Hospital Services :AMS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11,... Nov 11 2016
Lonmin buys Amplats stake in Pandora platinum mine Nov 11 2016
Anglo American Platinum announces the sale of its 42.5% interest in the Pandora Joint Venture to... Nov 11 2016
American Shared Hospital Services Reports Third Quarter Results Nov 10 2016
AMERICAN SHARED HOSPITAL SERVICES Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 10 2016
American Shared Hospital Services Reports 2016 Third Quarter Results Nov 10 2016
Trading statement for the twelve months ending 31 December 2016 Nov 10 2016
American Shared Hospital Services Announces Third Quarter 2016 Results Earnings Conference Call Nov 08 2016
American Shared Hospital Services Announces Third Quarter 2016 Results Earnings Conference Call Nov 08 2016
Industry’s first global shutter 48Mpixel CMOS image sensor from CMOSIS supports 8k image... Nov 06 2016
AMSC Reports Second Quarter Fiscal 2016 Financial Results and Provides Business Outlook Nov 02 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK